Cargando…
达芬奇机器人与电视胸腔镜辅助非小细胞肺癌根治术近期疗效配对的病例对照研究
BACKGROUND AND OBJECTIVE: Da Vinci Surgical System is one of the greatest inventions of the 20th century, which represents the development direction of the precise minimally invasive surgical techniques, the aim of this study was to comparing the short-term outcomes between da Vinci robot-assisted l...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973038/ https://www.ncbi.nlm.nih.gov/pubmed/29587943 http://dx.doi.org/10.3779/j.issn.1009-3419.2018.03.18 |
_version_ | 1783326534222741504 |
---|---|
collection | PubMed |
description | BACKGROUND AND OBJECTIVE: Da Vinci Surgical System is one of the greatest inventions of the 20th century, which represents the development direction of the precise minimally invasive surgical techniques, the aim of this study was to comparing the short-term outcomes between da Vinci robot-assisted lobectomy and video-assisted thoracic surgery (VATS) lobectomy for non-small cell lung cancer. METHODS: 45 pairs of non-small cell lung cancer patients underwent pulmonary lobectomy with da Vinci Robotic assisted thoracoscopic (RATS) and VATS approach during the same period from January 2014 to January 2017. The operative time, estimated blood loss (EBL), total number and total groups of dissected lymph nodes, postoperative duration of drainage, the first day volume of drainage, total volume of drainage were compared. RESULTS: No perioperative death and convertion to thoracotomy occured in both groups. There were significant difference between RATS group and VATS group in EBL [(50.30±32.33) mL vs (208.60±132.63) mL], the first day volume of drainage [(275.00±145.42) mL vs (347.60±125.80) mL], the dissected total number [(22.67±9.67) vs (15.51±5.41)] and total team [(6.31±1.43) vs (4.91±1.04)] of lymph node. There were no significant difference in other outcomes. CONCLUSIONS: RATS is safe and effective and took better short-outcomes than VATS in non-small cell lung cancer. |
format | Online Article Text |
id | pubmed-5973038 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | 中国肺癌杂志编辑部 |
record_format | MEDLINE/PubMed |
spelling | pubmed-59730382018-07-06 达芬奇机器人与电视胸腔镜辅助非小细胞肺癌根治术近期疗效配对的病例对照研究 Zhongguo Fei Ai Za Zhi 临床研究 BACKGROUND AND OBJECTIVE: Da Vinci Surgical System is one of the greatest inventions of the 20th century, which represents the development direction of the precise minimally invasive surgical techniques, the aim of this study was to comparing the short-term outcomes between da Vinci robot-assisted lobectomy and video-assisted thoracic surgery (VATS) lobectomy for non-small cell lung cancer. METHODS: 45 pairs of non-small cell lung cancer patients underwent pulmonary lobectomy with da Vinci Robotic assisted thoracoscopic (RATS) and VATS approach during the same period from January 2014 to January 2017. The operative time, estimated blood loss (EBL), total number and total groups of dissected lymph nodes, postoperative duration of drainage, the first day volume of drainage, total volume of drainage were compared. RESULTS: No perioperative death and convertion to thoracotomy occured in both groups. There were significant difference between RATS group and VATS group in EBL [(50.30±32.33) mL vs (208.60±132.63) mL], the first day volume of drainage [(275.00±145.42) mL vs (347.60±125.80) mL], the dissected total number [(22.67±9.67) vs (15.51±5.41)] and total team [(6.31±1.43) vs (4.91±1.04)] of lymph node. There were no significant difference in other outcomes. CONCLUSIONS: RATS is safe and effective and took better short-outcomes than VATS in non-small cell lung cancer. 中国肺癌杂志编辑部 2018-03-20 /pmc/articles/PMC5973038/ /pubmed/29587943 http://dx.doi.org/10.3779/j.issn.1009-3419.2018.03.18 Text en 版权所有©《中国肺癌杂志》编辑部2018 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/ |
spellingShingle | 临床研究 达芬奇机器人与电视胸腔镜辅助非小细胞肺癌根治术近期疗效配对的病例对照研究 |
title | 达芬奇机器人与电视胸腔镜辅助非小细胞肺癌根治术近期疗效配对的病例对照研究 |
title_full | 达芬奇机器人与电视胸腔镜辅助非小细胞肺癌根治术近期疗效配对的病例对照研究 |
title_fullStr | 达芬奇机器人与电视胸腔镜辅助非小细胞肺癌根治术近期疗效配对的病例对照研究 |
title_full_unstemmed | 达芬奇机器人与电视胸腔镜辅助非小细胞肺癌根治术近期疗效配对的病例对照研究 |
title_short | 达芬奇机器人与电视胸腔镜辅助非小细胞肺癌根治术近期疗效配对的病例对照研究 |
title_sort | 达芬奇机器人与电视胸腔镜辅助非小细胞肺癌根治术近期疗效配对的病例对照研究 |
topic | 临床研究 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973038/ https://www.ncbi.nlm.nih.gov/pubmed/29587943 http://dx.doi.org/10.3779/j.issn.1009-3419.2018.03.18 |
work_keys_str_mv | AT dáfēnqíjīqìrényǔdiànshìxiōngqiāngjìngfǔzhùfēixiǎoxìbāofèiáigēnzhìshùjìnqīliáoxiàopèiduìdebìnglìduìzhàoyánjiū AT dáfēnqíjīqìrényǔdiànshìxiōngqiāngjìngfǔzhùfēixiǎoxìbāofèiáigēnzhìshùjìnqīliáoxiàopèiduìdebìnglìduìzhàoyánjiū AT dáfēnqíjīqìrényǔdiànshìxiōngqiāngjìngfǔzhùfēixiǎoxìbāofèiáigēnzhìshùjìnqīliáoxiàopèiduìdebìnglìduìzhàoyánjiū AT dáfēnqíjīqìrényǔdiànshìxiōngqiāngjìngfǔzhùfēixiǎoxìbāofèiáigēnzhìshùjìnqīliáoxiàopèiduìdebìnglìduìzhàoyánjiū AT dáfēnqíjīqìrényǔdiànshìxiōngqiāngjìngfǔzhùfēixiǎoxìbāofèiáigēnzhìshùjìnqīliáoxiàopèiduìdebìnglìduìzhàoyánjiū AT dáfēnqíjīqìrényǔdiànshìxiōngqiāngjìngfǔzhùfēixiǎoxìbāofèiáigēnzhìshùjìnqīliáoxiàopèiduìdebìnglìduìzhàoyánjiū AT dáfēnqíjīqìrényǔdiànshìxiōngqiāngjìngfǔzhùfēixiǎoxìbāofèiáigēnzhìshùjìnqīliáoxiàopèiduìdebìnglìduìzhàoyánjiū AT dáfēnqíjīqìrényǔdiànshìxiōngqiāngjìngfǔzhùfēixiǎoxìbāofèiáigēnzhìshùjìnqīliáoxiàopèiduìdebìnglìduìzhàoyánjiū AT dáfēnqíjīqìrényǔdiànshìxiōngqiāngjìngfǔzhùfēixiǎoxìbāofèiáigēnzhìshùjìnqīliáoxiàopèiduìdebìnglìduìzhàoyánjiū AT dáfēnqíjīqìrényǔdiànshìxiōngqiāngjìngfǔzhùfēixiǎoxìbāofèiáigēnzhìshùjìnqīliáoxiàopèiduìdebìnglìduìzhàoyánjiū |